Home › Trial NCT04073784
Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.
- Trial IDNCT04073784
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorSun Yat-sen University
- Enrollment41
- Start date2019-06-08
- ConditionsNasopharyngeal Carcinoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.